• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

cancer

brain
Posted inNew Drugs, Oncology, Regulatory

Ojemda: Novel Treatment for Low-grade Glioma

by Mark Gubar April 23, 2024April 24, 2024

Tovorafenib represents a novel standard of care for the most prevalent central nervous system neoplasm affecting children.

cancer vaccine
Posted inClinical Trials, Oncology

Moderna mRNA-4157: Personalized Cancer Vaccine That Really Works

by Nik Resovski and Timur Burkhanayev April 15, 2024April 17, 2024

mRNA technologies paint an optimistic future in cancer treatment.

cancer cells
Posted inClinical Trials, Oncology

Autogene Cevumeran: Powerful mRNA Vaccine Against Pancreatic Cancer

by Julia Mardi April 11, 2024April 18, 2024

Personalized immunotherapy prolonged life in one-third of patients with pancreatic ductal adenocarcinoma.

liver cancer
Posted inClinical Trials, Oncology

Liver Cancer: Personalized Vaccine for Complete Remission

by Mark Gubar April 10, 2024April 25, 2024

Geneos Therapeutics has figured out how to cure unresectable hepatocellular carcinoma.

Posted inNew Drugs, Oncology, Regulatory

Datroway/Datverzo: Groundbreaking New Way to Treat Lung Cancer

by Julia Mardi and Mark Gubar March 27, 2024March 27, 2024

Datopotamab deruxtecan for the treatment of unresectable NSCLC after failure of first-line therapy.

Posted inNew Drugs, Oncology, Regulatory

Tevimbra: Immuno-Oncologic Treatment for Esophageal Cancer

by Julia Mardi March 19, 2024April 2, 2024

Tislelizumab for the treatment of unresectable or metastatic esophageal squamous cell carcinoma.

multiple-myeloma
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Tecvayli: New Drug for Multiple Myeloma

by Mark Gubar August 24, 2022September 8, 2022

Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.

Posts pagination

1 2 3 4 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×